| 1 |
Wang Z, Xie W, Guan H. Diverse Functions of MiR-425 in Human Cancer. DNA Cell Biol 2023;42:113-29. [PMID: 36796000 DOI: 10.1089/dna.2022.0557] [Reference Citation Analysis]
|
| 2 |
Du C, Han X, Zhang Y, Guo F, Yuan H, Wang F, Li M, Ning F, Wang W. DARS-AS1 modulates cell proliferation and migration of gastric cancer cells by regulating miR-330-3p/NAT10 axis. Open Med (Wars) 2022;17:2036-45. [PMID: 36568518 DOI: 10.1515/med-2022-0583] [Reference Citation Analysis]
|
| 3 |
Neyazi S, Ng M, Heckl D, Klusmann JH. Long noncoding RNAs as regulators of pediatric acute myeloid leukemia. Mol Cell Pediatr 2022;9:10. [PMID: 35596093 DOI: 10.1186/s40348-022-00142-2] [Reference Citation Analysis]
|
| 4 |
Khan K, Gogonea V, Fox PL. Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis. Transl Oncol 2022;19:101392. [PMID: 35278792 DOI: 10.1016/j.tranon.2022.101392] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
|
| 5 |
Zhang M, Zhou Z, Liu Z, Liu F, Zhao C. Exploring the potential biomarkers for prognosis of glioblastoma via weighted gene co-expression network analysis. PeerJ 2022;10:e12768. [PMID: 35111402 DOI: 10.7717/peerj.12768] [Reference Citation Analysis]
|
| 6 |
Huang X, Qi L, Lu W, Li Z, Li W, Li F. MYCN contributes to the sensitization of acute myelogenous leukemia cells to cisplatin by targeting SRY-box transcription factor 4. Bioengineered 2021. [PMID: 34709111 DOI: 10.1080/21655979.2021.1997697] [Reference Citation Analysis]
|
| 7 |
Feng Y, Wei G, Zhang L, Zhou H, Wang W, Guo P, Cheng C, Ji L, Cai Q, Feng Y, Tu H. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Bioengineered 2021;12:8217-32. [PMID: 34596006 DOI: 10.1080/21655979.2021.1982272] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 8 |
Huang X, Huang L, Xie Q, Zhang L, Huang S, Hong M, Li J, Huang Z, Zhang H. LncRNAs serve as novel biomarkers for diagnosis and prognosis of childhood ALL. Biomark Res 2021;9:45. [PMID: 34112247 DOI: 10.1186/s40364-021-00303-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 9 |
Cuadros M, García DJ, Andrades A, Arenas AM, Coira IF, Baliñas-Gavira C, Peinado P, Rodríguez MI, Álvarez-Pérez JC, Ruiz-Cabello F, Camós M, Jiménez-Velasco A, Medina PP. LncRNA-mRNA Co-Expression Analysis Identifies AL133346.1/CCN2 as Biomarkers in Pediatric B-Cell Acute Lymphoblastic Leukemia. Cancers (Basel) 2020;12:E3803. [PMID: 33348573 DOI: 10.3390/cancers12123803] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
